FDA Approves Generic Topamax to Prevent Seizures
The U.S. Food and Drug Administration has approved the first generic versions of
Topamax tablets (topiramate) to prevent seizures. Topiramate tablets in several different strengths have been
approved to be marketed by the following firms: Roxane Laboratories Inc., Par Pharmaceuticals Inc., Mylan
Pharmaceuticals Inc., Barr Laboratories Inc., TEVA Pharmaceuticals USA, Ranbaxy Laboratories Ltd., CIPLA Ltd.,
Glenmark Generics Ltd., Cobalt Laboratories, Apotex Inc., Zydus Pharmaceuticals USA, Aurobindo Pharma Ltd.,
Torrent Pharmaceuticals Ltd., Invagen Pharmaceuticals Inc., Unichem Laboratories Ltd., Sun Pharmaceuticals Ltd. and
Pliva Hrvatska. Read more...